Viro Perspectives

Learn more on the topic of Varicella Zoster Virus (VZV) via our ongoing series of clinical posts by David Kilpatrick, PhD and Abbas Vafai, PhD.

Shingles Varicella Zoster Virus - Viro Research

INTRODUCTION: Prevention of herpes zoster is key to the health and quality of life for almost all senior citizens. A study was performed to evaluate the effectiveness of the herpes zoster vaccines (recombinant zoster vaccine-RZV & zoster vaccine live-ZVL) against the incidence of herpes zoster and postherpetic neuralgia in older adults. According to the authors […]

Shingles Research - Varicella Zoster Virus

INTRODUCTION: Herpes zoster (HZ) results from the reactivation of latent varicella-zoster virus (VZV) in the dorsal root ganglia. VZV can then move along the sensory nerves to the skin, causing inflammatory lesions in the peripheral nerves. Occipital neuralgia reaches the fronto-orbital area through trigeminocervical inter-neuronal connections in the trigeminal spinal nuclei. The report here by […]

INTRODUCTION: The reactivation of varicella zoster virus, usually after the age of 50, results in shingles (Herpes Zoster-HZ). The risk of HZ increases with age and immunosuppression. The number of risk factors for HZ is unknown, therefore the aim of this study was to explore potential risk factors for HZ using survey data from a […]